_256_384.jpg){kind=logo}
News | September 16, 2022
Everstone acquires controlling stake in Softgel Healthcare
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
The acquisition reaffirms Infosys’ commitment to help global life sciences companies
Sandoz is planned to be incorporated in Switzerland and to be listed on the SIX Swiss Exchange, with an American Depositary Receipt (ADR) program in the US
The ninth acquisition since 2018
Formoterol Fumarate Inhalation Solution (RLD Perforomist) had estimated annual sales of US $282 million in the US
Driven by a strong commitment to better serve its global customers in medical and consumer products, this investment represents the largest capacity expansion in Cariflex’s existing accomplishments
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
The combined company will be able to better serve both our global and regional customers with local production
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
Subscribe To Our Newsletter & Stay Updated
